SFX by Ex Libris Inc.

Title:	Discovery of a Potent and Selective Oral Inhibitor of ERK1/2 (AZD0364) That Is Efficacious in Both Monotherapy and Combination Therapy in Models of Nonsmall Cell Lung Cancer (NSCLC)
Source:	Journal of Medicinal Chemistry [0022-2623] Ward, Richard yr:2019

Basic

Full text

Full text available via American Chemical Society Journals

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Advanced

Full text for other editions

Continued in part by: Acs Medicinal Chemistry Letters [1948-5875]

Full text available via American Chemical Society Journals

Year:

Volume:

Issue:

Start Page:

Full text available via PubMed Central

Year:

Volume:

Issue:

Start Page:

Author

Other articles by this author? -- in GeoRef

author:	last name	initials
author:

Other articles by this author? -- in Online Contents Geosciences

author:	last name	initials
author:

Other articles by this author? -- using Web of Science

author:	last name	initials
author:

Web Search

Find related information in a Web Search Engine

Search Terms:

Search for related information in Google Scholar

Search Terms: